|
Wyeth
Australia Pty Ltd
Overview
Wyeth has a long history of pioneering developments in pharmaceuticals
and biotechnology. Its efforts focus on finding and developing new
drugs that will enhance the quality of health care worldwide.
Wyeth has built a leadership position in the areas of women’s
health, gastrointestinal diseases, infectious diseases, neuroscience,
transplantation and immunology, musculoskeletal diseases, vaccines,
nutritionals, haemophilia, cardiovascular diseases, oncology and
other products.
Competitive
Advantages
One outcome of Wyeth’s research has been the development of
some of the most innovative vaccines in the health care arena that
help prevent suffering in infants and children around the world.
Wyeth is proud of the impact it has made on children’s lives,
and is dedicated to continually developing vaccines so children
could have a healthier future.
Technology
Wyeth is also a leader in the field of protein therapeutics. Its
experts have published groundbreaking studies in the fields of haematology,
immunology, bone and connective tissue biology, soft tissue repair,
and organ regeneration.
Corporate
Alliances/Partnerships
Partners
N/A
| Contact Person |
Dr Rachel A David |
 |
| Job Title |
Associate Director
Corporate Affairs |
| Address |
17-19 Solent Circuit,
Norwest Business Park |
| City/Suburb |
Baulkham Hills
NSW 2153 Australia |
| Email |
davidra@wyeth.com |
| Phone |
+61 2 9761 8453 |
| Fax |
+61 2 9023 0040 |
| Website |
www.wyeth.com.au |
back
|
